InvestorsHub Logo
Followers 60
Posts 7855
Boards Moderated 0
Alias Born 12/07/2007

Re: wenttocalifornia post# 5029

Thursday, 09/24/2015 7:02:42 PM

Thursday, September 24, 2015 7:02:42 PM

Post# of 5675
Yes, I know their is competition in regards to NPC. However, CTD knows this and wouldn't be going through trials and spending tons of money unless their product, Trappsol, was worth it. They are traveling the world getting all their ducks in a row. When approved, insurance will be paying tens of thousands a month, maybe more, to supply Trappsol to NPC patients. This revenue stream alone will raise pps greatly. Also, other products are possible and a pipeline will begin. I think the future is bright with ctdh, imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTH News